AstraZeneca's Benralizumab Treatment Can Reduce Symptoms Of Severe Asthma

The symptoms and risks of severe asthma are reduced by half with AstraZeneca's benralizumab injection every four weeks. The drug works by destroying the eosinophils, which are responsible for causing allergy and asthma, in airways and bloodstream.